Meg Perumal

1.0k total citations
17 papers, 843 citations indexed

About

Meg Perumal is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Meg Perumal has authored 17 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Meg Perumal's work include Medical Imaging Techniques and Applications (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Glioma Diagnosis and Treatment (3 papers). Meg Perumal is often cited by papers focused on Medical Imaging Techniques and Applications (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Glioma Diagnosis and Treatment (3 papers). Meg Perumal collaborates with scholars based in United Kingdom, Sweden and United States. Meg Perumal's co-authors include Eric O. Aboagye, Quang‐Dé Nguyen, Graham Smith, Erik Årstad, Matthias Glaser, Julius Leyton, John Latigo, Henryk Barthel, Sajinder K. Luthra and Bo Shan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Meg Perumal

17 papers receiving 832 citations

Peers

Countries citing papers authored by Meg Perumal

Since Specialization

Citations

This map shows the geographic impact of Meg Perumal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meg Perumal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meg Perumal more than expected).

Fields of papers citing papers by Meg Perumal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meg Perumal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meg Perumal. The network helps show where Meg Perumal may publish in the future.

Co-authorship network of co-authors of Meg Perumal

This figure shows the co-authorship network connecting the top 25 collaborators of Meg Perumal. A scholar is included among the top collaborators of Meg Perumal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meg Perumal. Meg Perumal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth 2013 ·British Journal of Cancer ·Maciej Kaliszczak, Sebastian Trousil, Ola Åberg, Meg Perumal, (unknown), Eric O. Aboagye	53
2	Radiosynthesis and in vivo tumor uptake of 2-deoxy-2-[18F]fluoro-myo-inositol 2012 ·Bioorganic & Medicinal Chemistry Letters ·Laurence Carroll, Meg Perumal, Neil Vasdev, Edward G. Robins, Eric O. Aboagye	5
3	Evaluation of 2-Deoxy-2-[18F]Fluoro-D-glucose- and 3′-Deoxy-3′-[18F]Fluorothymidine–Positron Emission Tomography as Biomarkers of Therapy Response in Platinum-Resistant Ovarian Cancer 2012 ·Molecular Imaging and Biology ·Meg Perumal, Euan A. Stronach, Hani Gabra, Eric O. Aboagye	20
4	Glucose Metabolism Measured by [18F]Fluorodeoxyglucose Positron Emission Tomography Is Independent of PTEN/AKT Status in Human Colon Carcinoma Cells 2011 ·Translational Oncology ·Quang‐Dé Nguyen, Meg Perumal, Todd Waldman, Eric O. Aboagye	19
5	Adaptation to HIF-1 deficiency by upregulation of the AMP/ATP ratio and phosphofructokinase activation in hepatomas 2011 ·BMC Cancer ·(unknown), Helen Troy, Yuen‐Li Chung, Paul M.J. McSheehy, Manuel Mayr, Xiaoke Yin, Lucy Ly, Kaye J. Williams, Rachel Airley, Adrian L. Harris, John Latigo, Meg Perumal, Eric O. Aboagye, David I. Perrett, Marion Stubbs, John R. Griffiths	24
6	Targeting Somatostatin Receptors: Preclinical Evaluation of Novel ¹⁸F-Fluoroethyltriazole-Tyr³-Octreotate Analogs for PET 2011 ·Journal of Nuclear Medicine ·Julius Leyton, (unknown), Meg Perumal, Bård Indrevoll, Matthias Glaser, Edward G. Robins, Andrew J.T. George, Alan Cuthbertson, Sajinder K. Luthra, Eric O. Aboagye	36
7	Radiosynthesis and pre-clinical evaluation of [18F]fluoro-[1,2-2H4]choline 2010 ·Nuclear Medicine and Biology ·Graham Smith, Yongjun Zhao, Julius Leyton, Bo Shan, Quang‐Dé Nguyen, Meg Perumal, David R. Turton, Erik Årstad, Sajinder K. Luthra, Edward G. Robins, Eric O. Aboagye	35
8	[18F]Fluoromethyl-[1,2-2H4]-Choline: A Novel Radiotracer for Imaging Choline Metabolism in Tumors by Positron Emission Tomography 2009 ·Cancer Research ·Julius Leyton, Graham Smith, Yongjun Zhao, Meg Perumal, Quang‐Dé Nguyen, Edward G. Robins, Erik Årstad, Eric O. Aboagye	30
9	Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [ ¹⁸ F]-labeled isatin sulfonamide 2009 ·Proceedings of the National Academy of Sciences ·Quang‐Dé Nguyen, Graham Smith, Matthias Glaser, Meg Perumal, Erik Årstad, Eric O. Aboagye	139
10	Imaging Pharmacodynamics of the α-Folate Receptor–Targeted Thymidylate Synthase Inhibitor BGC 945 2008 ·Cancer Research ·Radhakrishna G. Pillai, Martin Förster, Meg Perumal, (unknown), Julius Leyton, (unknown), Oksana Golovko, Ann L. Jackman, Eric O. Aboagye	30
11	Noninvasive imaging of cell proliferation following mitogenic extracellular kinase inhibition by PD0325901 2008 ·Molecular Cancer Therapeutics ·Julius Leyton, Graham Smith, (unknown), Meg Perumal, Quang‐Dé Nguyen, Franklin I. Aigbirhio, Oksana Golovko, (unknown), Paul Workman, Eric O. Aboagye	41
12	Design, Synthesis, and Biological Characterization of a Caspase 3/7 Selective Isatin Labeled with 2-[¹⁸F]fluoroethylazide 2008 ·Journal of Medicinal Chemistry ·Graham Smith, Matthias Glaser, Meg Perumal, Quang‐Dé Nguyen, Bo Shan, Erik Årstad, Eric O. Aboagye	110
13	Characterization of CCT129202, a novel Aurora kinase inhibitor and in vivo quantification of biological activity 2007 ·Florence Chan, Chongbo Sun, Meg Perumal, Quang‐Dé Nguyen, Vassilios Bavetsias, Edward McDonald, Vanessa Martins, Nicola E. Wilsher, Florence I. Raynaud, Melanie Valenti, Sue Eccles, Robert te Poele, Paul Workman, Eric O. Aboagye, Spiros Linardopoulos	1
14	Mechanism of action of the Aurora kinase inhibitor CCT129202 and in vivo quantification of biological activity 2007 ·Molecular Cancer Therapeutics ·Florence Chan, Chongbo Sun, Meg Perumal, Quang‐Dé Nguyen, Vassilios Bavetsias, Edward McDonald, Vanessa Martins, Nicola E. Wilsher, Florence I. Raynaud, Melanie Valenti, Sue Eccles, Robert te Poele, Paul Workman, Eric O. Aboagye, Spiros Linardopoulos	55
15	In vivoBiological Activity of the Histone Deacetylase Inhibitor LAQ824 Is detectable with 3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography 2006 ·Cancer Research ·Julius Leyton, John P. Alao, Marco Da Costa, Alexandra Stavropoulou, John Latigo, Meg Perumal, Radhakrishna G. Pillai, Qimin He, Peter Atadja, Eric W.‐F. Lam, Paul Workman, David M. Vigushin, Eric O. Aboagye	59
16	Redistribution of Nucleoside Transporters to the Cell Membrane Provides a Novel Approach for Imaging Thymidylate Synthase Inhibition by Positron Emission Tomography 2006 ·Cancer Research ·Meg Perumal, Radhakrishna G. Pillai, Henryk Barthel, Julius Leyton, John Latigo, Martin Förster, (unknown), Ann L. Jackman, Eric O. Aboagye	80
17	The uptake of 3?-deoxy-3?-[18F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levels 2004 ·European Journal of Nuclear Medicine and Molecular Imaging ·Henryk Barthel, Meg Perumal, John Latigo, Qimin He, Frank Brady, Sajinder K. Luthra, Patricia M. Price, Eric O. Aboagye	106

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact